Legal & General Group Plc - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$17,211
-36.0%
4,960
-14.3%
0.00%
Q2 2023$26,900
+13.1%
5,785
+12.4%
0.00%
Q1 2023$23,775
-42.8%
5,1460.0%0.00%
Q4 2022$41,580
+59.9%
5,146
+12.0%
0.00%
Q3 2022$26,000
+36.8%
4,595
+23.8%
0.00%
Q2 2022$19,000
-79.3%
3,712
-67.1%
0.00%
Q1 2022$92,000
-44.9%
11,2700.0%0.00%
Q4 2021$167,000
-21.6%
11,2700.0%0.00%
Q3 2021$213,000
+131.5%
11,270
+129.0%
0.00%
Q2 2021$92,000
+17.9%
4,921
+44.3%
0.00%
Q1 2021$78,000
+14.7%
3,410
+8.6%
0.00%
Q4 2020$68,000
+126.7%
3,140
+6.9%
0.00%
Q3 2020$30,000
+42.9%
2,937
+10.7%
0.00%
Q2 2020$21,000
+50.0%
2,654
+90.0%
0.00%
Q1 2020$14,000
-33.3%
1,397
-26.4%
0.00%
Q4 2019$21,000
+23.5%
1,899
+4.4%
0.00%
Q3 2019$17,000
-19.0%
1,8190.0%0.00%
Q2 2019$21,000
+90.9%
1,819
+84.3%
0.00%
Q1 2019$11,000
+22.2%
9870.0%0.00%
Q4 2018$9,0009870.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders